Heat Biologics, Inc.
INTRATUMORAL VACCINATION

Last updated:

Abstract:

The present disclosure relates to, inter alia, a method for treating a tumor by intratumorally delivering an effective amount of a composition comprising an expression vector that comprises a first nucleotide sequence encoding a secretable vaccine protein, and a second nucleotide sequence encoding a T cell costimulatory fusion protein.

Status:
Application
Type:

Utility

Filling date:

3 Apr 2018

Issue date:

30 Jan 2020